SiriusPoint Ltd. (SPNT)
NYSE NYSE Primary 
XFRA 
SiriusPoint (SPNT) Tops Q3 Earnings and Revenue Estimates
SiriusPoint (SPNT) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.03 per share a year ago.
SiriusPoint (SPNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
SiriusPoint (SPNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should Value Investors Buy SiriusPoint (SPNT) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
SiriusPoint Ltd. (SPNT) Q2 2025 Earnings Call Transcript
SiriusPoint Ltd. (NYSE:SPNT ) Q2 2025 Earnings Conference Call August 4, 2025 8:30 AM ET Company Participants James J.
SiriusPoint (SPNT) Q2 Earnings and Revenues Top Estimates
SiriusPoint (SPNT) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.57 per share a year ago.
Wall Street Analysts See a 29.37% Upside in SiriusPoint (SPNT): Can the Stock Really Move This High?
The consensus price target hints at a 29.4% upside potential for SiriusPoint (SPNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
SiriusPoint: A Reinsurance Underdog Set For A Breakout
SiriusPoint has successfully executed a strategic turnaround, improving underwriting discipline and restoring profitability since 2023 despite catastrophe losses. The company's book value per share has grown 31% since Q4 2022, supporting a potential re-rating to 1.3–1.4x P/B and 30% upside. Forward P/E of 9.3 is below the industry average, indicating undervaluation if underwriting margins and net income remain stable or improve.
Analysts Estimate SiriusPoint (SPNT) to Report a Decline in Earnings: What to Look Out for
SiriusPoint (SPNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are Investors Undervaluing SiriusPoint (SPNT) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is SiriusPoint (SPNT) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
SiriusPoint And Its Preferred Stock Are Underrated Opportunities In The Insurance Sector
SiriusPoint has outperformed the S&P 500 and peers, highlighting strong management and market position. The company boasts investment-grade credit ratings, reinforcing its financial strength and reliability as a preferred equity issuer. SPNT.PR.B preferred stock offers a high 7.01% yield to call, resettable rate, and growth potential, appealing to long-term income investors.
SiriusPoint Ltd. (SPNT) Q1 2025 Earnings Call Transcript
SiriusPoint Ltd. (NYSE:SPNT ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Liam Blackledge - Investor Relations & Strategy Manager Scott Egan - Chief Executive Officer Jim McKinney - Chief Financial Officer Operator Good morning, ladies and gentlemen, and welcome to SiriusPoint's First Quarter 2025 Earnings Conference Call.
